Other Species / Isoforms
  DNAM-1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
N83
AERVYFLNSTMASNN
0 1
DNAM-1 (human) AERVYFLNSTMASNN N83
DNAM-1 (mouse) LHRVHFLnSTVGFRN N84-ng
DNAM-1 (rat) LHRVHFQNATVGFRN N97
K167-ub
VQAVRWEkIQPRQID
0 1
DNAM-1 (human) VQAVRWEkIQPRQID K167-ub
DNAM-1 (mouse) VQQVIWEKVQPHQVD K168
DNAM-1 (rat) VQLVIWEKVQPHQVD K181
Y249-p
EGKTDNQytLFVAGG
0 1
DNAM-1 (human) EGKTDNQytLFVAGG Y249-p
DNAM-1 (mouse) DGGTNKHFILPIVGG F251
DNAM-1 (rat) DGGTNNHFILLIVGG F264
T250-p
GKTDNQytLFVAGGT
0 1
DNAM-1 (human) GKTDNQytLFVAGGT T250-p
DNAM-1 (mouse) GGTNKHFILPIVGGL I252
DNAM-1 (rat) GGTNNHFILLIVGGL I265
S290-p
RRDLFTEsWDtQkAP
Upstream
0 8
Treatment
  • antibody
DNAM-1 (human) RRDLFTEsWDtQkAP S290-p
DNAM-1 (mouse) VRIPLKEPRDKQSKV P290
DNAM-1 (rat) VRTPLKELRDKQSKV L303
T293-p
LFTEsWDtQkAPNNY
0 7
DNAM-1 (human) LFTEsWDtQkAPNNY T293-p
DNAM-1 (mouse) PLKEPRDKQSKVATN K293
DNAM-1 (rat) PLKELRDKQSKVATN K306
K295-ub
TEsWDtQkAPNNYRS
0 2
DNAM-1 (human) TEsWDtQkAPNNYRS K295-ub
DNAM-1 (mouse) EPRDKQSKVATNCRS K296
DNAM-1 (rat) ELRDKQSKVATNCRs K309
S302
kAPNNYRSPISTSQP
0 1
DNAM-1 (human) kAPNNYRSPISTSQP S302
DNAM-1 (mouse) KVATNCRSPTSPIQS S303
DNAM-1 (rat) KVATNCRsPTsPIQT S316-p
S305
NNYRSPISTSQPTNQ
0 1
DNAM-1 (human) NNYRSPISTSQPTNQ S305
DNAM-1 (mouse) TNCRSPTSPIQSTDD S306
DNAM-1 (rat) TNCRsPTsPIQTTDD S319-p
S313-p
TSQPTNQsMDDTRED
0 1
DNAM-1 (human) TSQPTNQsMDDTRED S313-p
DNAM-1 (mouse) gap -
DNAM-1 (rat) gap -
Y322-p
DDTREDIyVNyPTFs
Upstream
Downstream
6 68
Effects on Modified Protein
  • activity, induced
  • phosphorylation
Effects on Biological Processes:
  • cell adhesion, induced
  • cell growth, induced
  • signaling pathway regulation
Putative in vivo kinases:
  • Fyn (human)
Regulatory protein:
  • CD3D (human)
  • PVR (human)
  • TIGIT (human)
Treatment
  • anti-CD226
  • anti-TIGIT
  • antibody
  • vanadate
DNAM-1 (human) DDTREDIyVNyPTFs Y322-p
DNAM-1 (mouse) DDEKEDIyVNYPTFs Y319-p
DNAM-1 (rat) DDEKEDIYVNYPTFS Y332
Y325-p
REDIyVNyPTFsRRP
Upstream
1 19
Treatment
  • vanadate
DNAM-1 (human) REDIyVNyPTFsRRP Y325-p
DNAM-1 (mouse) KEDIyVNYPTFsRRP Y322
DNAM-1 (rat) KEDIYVNYPTFSRRP Y335
S329-p
yVNyPTFsRRPKTRV
Upstream
Downstream
4 0
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • phorbol_ester
DNAM-1 (human) yVNyPTFsRRPKTRV S329-p
DNAM-1 (mouse) yVNYPTFsRRPKPRL S326-p
DNAM-1 (rat) YVNYPTFSRRPKPRF S339